| 2008 |
|
Tae Sung Park, MD - Cerebral Microvascular Injury in the Neonate and Selective Dorsal Rhizotomy for Spastic Cerebral Palsy |
| 2009 |
|
Mitchel S. Berger, MD - Impacting Outcome for Patients with Gliomas: A Convergence of Thoughts and Practice |
| 2010 |
|
Andres M. Lozano, MD, PhD - Tuning the Circuits in the Brain to Improve Function |
| 2011 |
|
J. Marc Simard, MD, PhD - SUR1—Promising Molecular Target in CNS Ischemia and Trauma |
| 2012 |
|
Robert M. Friedlander, MD - Role of Caspase Cell Death Pathways in Neurological Diseases |
| 2013 |
|
Michael G. Fehlings, MD, PhD - Repair and Regeneration of the Injured Spinal Cord: From Molecule to Man |
| 2014 |
|
Matthew A. Howard, III, MD - Neurosurgery Research: Creativity, Adaptability, and Survival |
| 2015 |
|
Ian Pollack, MD - Molecular Markers and Molecularly Targeted Therapies for Childhood Brain Tumors |
| 2016 |
|
E. Sander Connolly, Jr. MD - Neuroinflamination and the evolving pharmacotherapy of acute stroke. |
| 2017 |
|
Gary K. Steinberg, MD, Phd - A Lifelong Quest to Understand and treat cerebrovascular disease |
| 2018 |
|
John Sampson, MD - Brain Tumor Immunotherapy: Turning Money into Knowledge and Knowledge to Money |
| 2019 |
|
Michael D. Taylor, MD - Pediatric Brain tumors in the Molecular Era |
| 2020-2021 |
|
Murat Gunel, MD |
| 2022 |
|
Frederick F. Lang, MD - Evolution of Biological Therapies in the Pursuit of the Elusive Cure for Glioblastoma |
| 2023 |
|
Edward F. Chang, MD, - Deciphering the Neural Code of Speech |